|

| 产地 | France |
| 品牌 | AntibodySystem |
| 货号 | YHC20201 |
| 用途 | 仅用于科研 |
| 包装规格 | 100 μg |
| 纯度 | 0.95% |
| CAS编号 | |
| 是否进口 | 否 |
| 货号 | YHC20201 |
| 产品名称 | Recombinant Human CDK1 Protein, N-His |
| 规格 | 100 μg |
| 价格 | 1880 |
| 状态 | Lyophilized |
| 储存缓冲液 | Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
| 纯度 | >90% as determined by SDS-PAGE. |
| 应用 | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| 内毒水平 | Please contact with the lab for this information. |
| 表达系统 | E. coli |
| Accession | P06493 |
| 蛋白长度 | Met1-Met297 |
| 预测分子量 | 36.41 kDa |
| 稳定性与储存条件 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 重悬 | Reconstitute in sterile water for a stock solution. |
| 别名 | CDC28A, CDKN1, P34CDC2, p34 protein kinase, CDK1, Cell division protein kinase 1, Cell division control protein 2 homolog, CDC2, Cyclin-dependent kinase 1 |
| 物种 | Homo sapiens (Human) |
| 运输 | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| 备注 | For research use only. |
CDK1(周期蛋白依赖性激酶1),细胞周期核心调控蛋白,结合周期蛋白后激活,驱动细胞完成分裂进程,把控细胞增殖周期运转。广泛存在于增殖活跃的细胞中,蛋白功能紊乱会造成细胞周期运转失常,是细胞增殖、周期调控方向的经典研究靶点。
前沿相关研究:
1.Naphthalimide derivative attenuates tumor growth of wild-type p53-expressing U87 glioma cells in vitro and in vivo through a biphasic dose-dependent mechanism: A switch from cell cycle to apoptosis., PMID:40294493
2.Identification and validation of programmed cell death related biomarkers for the treatment and prevention COVID-19., PMID:40300201
3.IGF2BP3 recruits NUDT21 to regulate SPTBN1 alternative polyadenylation and drive ovarian cancer progression., PMID:40301554
4.SNRPB2: a prognostic biomarker and oncogenic driver in esophageal cancer via β-catenin/c-Myc signaling., PMID:40303992
5.Membrane-anchored tissue inhibitor of matrix metalloproteinase (TIMP)-1 promotes cell death in head and neck cancer by inducing DNA damage, accumulating collagen II and disrupting cell survival mechanisms., PMID:40306502
6.Cell cycle duration determines oncogenic transformation capacity., PMID:40307557
7.Identification and validation of susceptibility modules and hub genes of adrenocortical carcinoma through WGCNA and machine learning., PMID:40317315
8.Therapy-induced senescence of glioblastoma cells is determined by the p21CIP1-CDK1/2 axis and does not require activation of DREAM., PMID:40319068